CTI BioPharma to Present at the Needham Healthcare Conference on Wednesday, Apr. 15
SEATTLE, April 8, 2020 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced that management will provide a corporate overview at the Needham Healthcare Conference at 10:40 a.m. EDT. The conference will be held in a virtual meeting format.
Presentation details:
Event:
Needham Healthcare Conference
Date:
Wednesday, Apr. 15
Time:
10:40 a.m. EDT
The presentation will be webcast live and available for replay from the Investors section of CTI BioPharma's website at www.ctibiopharma.com.
About CTI BioPharma Corp.
We are a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. We concentrate our efforts on treatments that target blood-related cancers where there is an unmet medical need. In particular, we are focused on evaluating pacritinib, our sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. We are headquartered in Seattle, Washington.
The Jackson Laboratory (JAX), an independent, nonprofit biomedical research organization, and AbTherx, an innovator in biotechnology, announced a strategic partnership to develop and commercialize cutting-edge tools to expedite antibody discovery and...
QuickLogic Corporation , a developer of embedded FPGA (eFPGA) IP, ruggedized FPGAs and Endpoint AI solutions, is set to showcase its newest developments at the Single Event Effects Symposium & Military and Aerospace Programmable Logic Devices...
Altisource Asset Management Corporation ("AAMC" or the "Company") posts the attached progress report for April 2024 concerning Project Alpha, Phase II, presented by Seabird Technologies Limited in connection with that certain Non-Exclusive Patent...
Constellation Software Inc. ("Constellation" or the "Company") today announced its financial results for the first quarter ended March 31, 2024 and declared a $1.00 per share dividend payable on July 11, 2024 to all common shareholders of record at...
mdf commerce inc. ("mdf" or the "Company") , a SaaS leader in digital commerce technologies, announced today that at the Company's special meeting (the "Meeting") of its shareholders (the "Shareholders") held earlier today, an overwhelming majority...
Givex Corp. ("Givex" or the "Corporation") , is pleased to announce the results of its annual and special meeting of shareholders held on May 10, 2024 (the "Meeting"), with a majority voting in accordance with management recommendations....
